CN111543587A - Cordyceps sinensis edible noodles with effect of reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof - Google Patents
Cordyceps sinensis edible noodles with effect of reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof Download PDFInfo
- Publication number
- CN111543587A CN111543587A CN202010336896.6A CN202010336896A CN111543587A CN 111543587 A CN111543587 A CN 111543587A CN 202010336896 A CN202010336896 A CN 202010336896A CN 111543587 A CN111543587 A CN 111543587A
- Authority
- CN
- China
- Prior art keywords
- high blood
- parts
- cordyceps sinensis
- noodles
- blood pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 48
- 239000008280 blood Substances 0.000 title claims abstract description 48
- 235000012149 noodles Nutrition 0.000 title claims abstract description 40
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 32
- 241001248610 Ophiocordyceps sinensis Species 0.000 title claims abstract description 27
- 230000000694 effects Effects 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 150000002632 lipids Chemical class 0.000 title claims description 17
- 235000013312 flour Nutrition 0.000 claims abstract description 17
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 14
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 10
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 10
- 244000017020 Ipomoea batatas Species 0.000 claims abstract description 10
- 235000002678 Ipomoea batatas Nutrition 0.000 claims abstract description 10
- 241001506047 Tremella Species 0.000 claims abstract description 10
- 241000233866 Fungi Species 0.000 claims abstract description 8
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 7
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 7
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 7
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 7
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 7
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 7
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 7
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 7
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 7
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 7
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 7
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 7
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 7
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 7
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 7
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 7
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 7
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 7
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 7
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 7
- 241000405414 Rehmannia Species 0.000 claims abstract description 7
- 244000078912 Trichosanthes cucumerina Species 0.000 claims abstract description 7
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims abstract description 7
- 240000008042 Zea mays Species 0.000 claims abstract description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 7
- 235000006533 astragalus Nutrition 0.000 claims abstract description 7
- 235000007215 black sesame Nutrition 0.000 claims abstract description 7
- 235000005822 corn Nutrition 0.000 claims abstract description 7
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 235000008113 selfheal Nutrition 0.000 claims abstract description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 7
- 235000020238 sunflower seed Nutrition 0.000 claims abstract description 7
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 6
- 240000006240 Linum usitatissimum Species 0.000 claims abstract description 5
- 235000004431 Linum usitatissimum Nutrition 0.000 claims abstract description 5
- 108010068370 Glutens Proteins 0.000 claims abstract description 4
- 235000021312 gluten Nutrition 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000004140 cleaning Methods 0.000 claims description 9
- 244000075850 Avena orientalis Species 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000003825 pressing Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 244000046146 Pueraria lobata Species 0.000 claims description 4
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 4
- 241000221377 Auricularia Species 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 230000018044 dehydration Effects 0.000 claims description 3
- 238000006297 dehydration reaction Methods 0.000 claims description 3
- 230000000249 desinfective effect Effects 0.000 claims description 3
- 239000003517 fume Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000007602 hot air drying Methods 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000005096 rolling process Methods 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 2
- 241000190633 Cordyceps Species 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 241000209763 Avena sativa Species 0.000 abstract 1
- 235000007558 Avena sp Nutrition 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 17
- 230000036772 blood pressure Effects 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 9
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 9
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 9
- 201000001421 hyperglycemia Diseases 0.000 description 8
- 235000005686 eating Nutrition 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- -1 lipid alcohols Chemical class 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 229960001597 nifedipine Drugs 0.000 description 3
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 3
- 239000007939 sustained release tablet Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229940127088 antihypertensive drug Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 210000004026 tunica intima Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010053649 Vascular rupture Diseases 0.000 description 1
- 206010057469 Vascular stenosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000528 amlodipine Drugs 0.000 description 1
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 description 1
- 229940041381 amlodipine pill Drugs 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229930002161 purine alkaloid Natural products 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/109—Types of pasta, e.g. macaroni or noodles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/105—Sweet potatoes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a cordyceps sinensis edible noodle with the effect of reducing high blood pressure, high blood sugar and a preparation method thereof, wherein the cordyceps sinensis edible noodle comprises buckwheat flour, high gluten flour, cordyceps sinensis, linseed, oat, hawthorn, black fungus, corn, Chinese yam, tremella, black sesame, purple sweet potato, sunflower seed, coix seed, bitter gourd, sodium carbonate, radix puerariae, astragalus membranaceus, cassia seed, selfheal, rehmannia root and edible salt; based on the consideration of the overall quality of three highs, the cordyceps sinensis.
Description
Technical Field
The invention relates to a cordyceps sinensis edible noodle with an effect of reducing high blood pressure, high blood lipid and high blood sugar and a preparation method thereof.
Background
Hypertension, hyperglycemia and hyperlipidemia. They may exist alone or in association with each other. Hyperlipidemia can cause vascular embolism; hypertension can cause cerebral hemorrhage and cerebral vascular rupture; hyperglycemia can cause diabetes, and they are all fatal "first killers" in humans. Any one of the three diseases appears, and three-high disease is easy to form in the later period. Due to long-term eating habits, the lipid content and alcohol content in the food are too much. Meanwhile, reasonable movement does not exist to promote the metabolism of lipid alcohols, so that lipid alcohols in the body are gradually increased and doped in blood, capillary vessels are blocked, and the lipid alcohols are easily combined with free mineral ions in the body to form thrombus. Thrombus is easily accumulated and calcified at the corners or the bottle necks of the blood vessels. Meanwhile, the thrombus is more and more, so that the diameter of the blood vessel is reduced. In order to maintain a sufficient blood supply, the heart increases blood pressure, causing hypertensive diseases. If the blood pressure is too high, the blood vessel can be burst, and then the blood cardiovascular and cerebrovascular diseases are generated.
The normal vascular intima of a person affected by the interaction of hyperlipidemia and hypertension is smooth and fluent, yellow atheromatous plaque is gradually deposited under the vascular intima if the blood fat is increased, and if the blood fat is not treated, the blood fat is gradually broken, bleeding, vascular stenosis and blood fluidity are weakened, so that the blood fat is increased, the blood pressure is increased, in addition, the long-term accumulation of the blood fat can cause vascular sclerosis, the elasticity of the vascular wall is weakened, and the blood pressure is increased, which means that if a patient affected by the interaction of the hyperlipidemia and hypertension suffers from the hyperlipidemia and the hypertension at the same time, the sensitivity of antihypertensive drugs can be reduced due to the hyperlipidemia, so the treatment of the hypertension and the hyperlipidemia needs to be carried out in a unilateral way and should be coordinated. The mutual influence of hyperlipidemia and hyperglycemia many diabetes patients are accompanied by hyperlipidemia, and hyperlipidemia is considered as a complication of diabetes, and cardiovascular and cerebrovascular complications are easily caused by hyperlipidemia increasing patients. The majority of diabetic patients have lipid metabolism disorder, and diabetes causes increased blood lipid mainly due to insulin deficiency, so that lipase activity in vivo is reduced, and blood lipid is easily increased. On the other hand, diabetes is accompanied by disorders of protein, water, fat and dielectric substances. On the other hand, if the diabetic patient takes too much exercise, lipid synthesis in the body is increased, and blood fat is increased. The mutual influence of hypertension and diabetes, especially obesity type hypertension patients are often accompanied with diabetes, and the main reason is that the diabetes easily causes kidney damage, thereby increasing the blood pressure.
Although a plurality of medicines for treating hyperlipidemia, hypertension and hyperglycemia in the market at present are treated separately and lack the consideration of overall treatment, the hyperlipidemia, the hypertension and the hyperglycemia are in internal connection and often affect and involve each other, so that the treatment effect of the existing medicines is quite limited.
Disclosure of Invention
Aiming at the defects of the prior art, the invention solves the problems that: provides the cordyceps sinensis edible noodles for reducing high blood fat, high blood pressure and high blood sugar, and has good treatment effect.
In order to solve the problems, the technical scheme adopted by the invention is as follows:
the cordyceps sinensis edible noodles with the effect of reducing high blood pressure, high blood lipid and high blood sugar comprise the following raw materials in parts by weight: 100 parts of buckwheat flour, 80 parts of high gluten flour, 20 parts of cordyceps sinensis, 10 parts of linseed, 10 parts of oat, 5 parts of hawthorn, 5 parts of black fungus, 2 parts of corn, 2 parts of Chinese yam, 2 parts of tremella, 2 parts of black sesame, 2 parts of purple sweet potato, 2 parts of sunflower seed, 1 part of coix seed, 1 part of bitter gourd, 1 part of sodium carbonate, 1 part of kudzu root, 0.5 part of astragalus membranaceus, 0.5 part of cassia seed, 0.1 part of selfheal, 0.1 part of rehmannia and 0.2 part of edible salt.
A preparation method of cordyceps sinensis edible noodles with an effect of reducing high blood pressure, high blood lipid and high blood sugar comprises the following steps:
s1, cleaning raw materials: respectively putting Cordyceps, fructus crataegi, herba Avenae Fatuae, Auricularia, semen Maydis, semen Lini, rhizoma Dioscoreae, Tremella, semen Sesami Niger, purple sweet potato, semen Helianthi, Coicis semen, fructus Momordicae Charantiae, radix Puerariae, semen Cassiae, radix astragali, Prunellae Spica, and rehmanniae radix into different containers, cleaning in cold water, taking out, draining water, pulverizing, and processing;
s2, crushing the raw materials: respectively crushing cleaned cordyceps sinensis, hawthorn, oat, black fungus, corn, flaxseed, Chinese yam, tremella, black sesame, purple sweet potato, sunflower seed, coix seed, bitter gourd, radix puerariae, cassia seed, astragalus mongholicus, selfheal and rehmannia root to ensure that the fineness of the raw materials meets the requirement of noodle making;
s3 mixing and stirring: pouring the crushed raw materials, buckwheat flour, high-gluten flour, edible salt, sodium carbonate and water into a stainless steel container, and fully stirring to form a smooth dough; the mass ratio of the added amount of the water to the buckwheat flour is 5: 4;
s4, making dough cover and noodles: putting the agglomerated mixed materials on a chopping board, and pressing the agglomerated mixed materials into dough sheets with uniform thickness by using a rolling pin; putting the pressed dough cover on a noodle machine, and pressing to form noodles with uniform length;
s5, drying, disinfecting and packaging: and (3) placing the prepared noodles in a sterile fume hood for dehydration and drying, then placing the noodles in an oven for heating and hot air drying, finally placing the noodles in a sterile room for natural cooling, and packaging and warehousing after passing inspection.
Further, the cleaning time in the step S1 is 3-5 min.
Further, in the step S2, the powder is sieved with a 100-mesh sieve plate.
Further, in step S3, the raw materials are fully stirred into a smooth dough, and then the process is stopped for 18 to 22min to wait for processing.
The invention has the advantages of
Based on the consideration of the overall treatment of the hypertension, the hyperlipidemia and the hyperglycemia, a plurality of components are mixed to achieve synergistic effect, and the overall treatment can be performed.
Detailed Description
The present invention will be described in further detail below.
The cordyceps sinensis edible noodles with the effect of reducing high blood pressure, high blood lipid and high blood sugar comprise the following raw materials in parts by weight: 100 parts of buckwheat flour, 80 parts of high gluten flour, 20 parts of cordyceps sinensis, 10 parts of linseed, 10 parts of oat, 5 parts of hawthorn, 5 parts of black fungus, 2 parts of corn, 2 parts of Chinese yam, 2 parts of tremella, 2 parts of black sesame, 2 parts of purple sweet potato, 2 parts of sunflower seed, 1 part of coix seed, 1 part of bitter gourd, 1 part of sodium carbonate, 1 part of kudzu root, 0.5 part of astragalus membranaceus, 0.5 part of cassia seed, 0.1 part of selfheal, 0.1 part of rehmannia and 0.2 part of edible salt.
A preparation method of cordyceps sinensis edible noodles with an effect of reducing high blood pressure, high blood lipid and high blood sugar comprises the following steps:
s1, cleaning raw materials: the method comprises the steps of respectively putting cordyceps sinensis, hawthorn, oat, black fungus, corn, linseed, Chinese yam, tremella, black sesame, purple sweet potato, sunflower seed, coix seed, bitter gourd, kudzu vine root, cassia seed, astragalus, selfheal and rehmannia root into different containers, cleaning in cold water, fishing out, draining water, crushing and processing, wherein the cleaning time is 3-5 min.
S2, crushing the raw materials: respectively crushing cleaned Cordyceps sinensis, fructus crataegi, herba Avenae Fatuae, Auricularia, semen Maydis, semen Lini, rhizoma Dioscoreae, Tremella, semen Sesami Niger, purple sweet potato, semen Helianthi, Coicis semen, fructus Momordicae Charantiae, radix Puerariae, semen Cassiae, radix astragali, Prunellae Spica, and rehmanniae radix to make the raw materials reach the requirement of noodle preparation, and sieving with 100 mesh sieve plate during crushing.
S3 mixing and stirring: pouring the crushed raw materials, buckwheat flour, high-gluten flour, edible salt, sodium carbonate and water into a stainless steel container, and fully stirring to form a smooth dough; the mass ratio of the water to the buckwheat flour is 5:4, and the raw materials are fully stirred into a smooth dough and then are stopped for 18-22 min to wait for processing.
S4, making dough cover and noodles: putting the agglomerated mixed materials on a chopping board, and pressing the agglomerated mixed materials into dough sheets with uniform thickness by using a rolling pin; putting the pressed dough cover on a noodle machine, and pressing to obtain noodles with uniform length.
S5, drying, disinfecting and packaging: and (3) placing the prepared noodles in a sterile fume hood for dehydration and drying, then placing the noodles in an oven for heating and hot air drying, finally placing the noodles in a sterile room for natural cooling, and packaging and warehousing after passing inspection.
The following is a test example of the edible noodles prepared by the present invention for reducing hypertension, hyperglycemia and hyperlipidemia.
The invention is verified by 64 patients, wherein 32 men and 32 women have the age of 68 at the maximum age and 36 at the minimum age, the edible noodle prepared by the invention is eaten five times per week, each time of supper is eaten, one month is a treatment course, 85% of the symptoms of dizziness, fatigue, insomnia, amnesia, limb numbness, chest distress and the like of the patients disappear after continuously eating three treatment courses, and the original glucose, triglyceride, cholesterol, high-density lipoprotein and low-density lipoprotein are all higher to be in a normal range according to the test result, so that the clinical application of the invention has obvious curative effect.
The following are typical examples of the edible noodles prepared by the present invention for reducing hypertension, hyperglycemia and hyperlipidemia.
Mr. Ju, 52 years old, before eating the invention, people have hypertension for more than 5 years, when the hypertension is found to be 155mm Hkg/90mm Hkg, nifedipine sustained-release tablets are orally taken 10mkg each day; after eating the health food for 3 months, other antihypertensive drugs are not used, and the blood pressure is recovered to a normal value and is kept within the range of 127mm Hkg/80mm Hkg.
For Liu women, the age is 66 years old, before the Liu women eat the nifedipine sustained-release tablet, the hypertension is improved for 9 years, the blood pressure is 155/95mm Hkg, the fasting blood sugar is 8.5mmol/L, the nifedipine sustained-release tablet is orally taken for 10 mckg every day, 4 tablets every day, and 2 tablets in the morning and at night are controlled; after eating the invention for 3 months, the symptoms such as edema of face and limbs and the like gradually disappear, the blood pressure is stable and kept in the range of 135mm Hkg/85mm Hkg, and the fasting blood sugar is also reduced to the normal range.
Considering that the patients are 48 years old, before eating the oral amlodipine pill, the hypertension and the hyperlipidemia are more than 4 years old, and the headache is accompanied with insomnia symptoms, the blood pressure is 160mm Hkg/90mm Hkg, and the oral amlodipine tablet, the ginkgo leaf tablet and the aspirin enteric-coated tablet are relieved but frequently and repeatedly attack; after eating the invention for 3 months, all other blood pressure-reducing and lipid-lowering medicines are stopped, the blood pressure is kept within the range of 118mm Hkg/80mm Hkg, and the insomnia condition is improved.
Cordycepin is one of important active ingredients of cordyceps sinensis, has various medical and health-care effects, and has nourishing and health-care effects besides the medical effect, so that the cordycepin is increasingly paid more attention by people. Cordycepin is a nucleic acid derivative containing nitrogen glycoside, belongs to purine alkaloid, is a nucleoside antibiotic, and has broad-spectrum antibacterial activity. Cordycepin has biological activity of inhibiting bacteria, inhibiting virus, killing parasite, regulating immunity, resisting tumor and resisting fungi. Can be clinically used for treating cancers and leukemia, and has the functions of dilating trachea and bronchus, obviously enhancing epinephrine and resisting aging.
Cordycepin starts from invigorating qi and blood, and skillfully combines nourishing yin, invigorating spleen, benefiting qi and activating blood by enhancing the metabolic capability of various organs such as liver, spleen, pancreatic islet and the like; cordycepin can enhance constitution of patients, and correct sugar, protein and fat metabolism disorder, thereby lowering blood sugar; cordycepin can increase blood flow of canine coronary artery, reduce resistance of coronary artery, brain and peripheral blood vessel, increase myocardial nutrition blood flow, reduce cholesterol and triglyceride in blood, increase high density lipoprotein, and relieve atherosclerosis, thereby lowering blood pressure and blood lipid; cordycepin can promote blood circulation, reduce blood viscosity, hyperlipemia and platelet aggregation rate, and increase blood flow rate; most importantly, the cordycepin can purify blood, restore blood vessel elasticity and improve microcirculation under the advantage of integral regulation, thereby fundamentally avoiding the generation of complications.
Based on the consideration of the overall quality of three highs, the cordyceps sinensis.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (5)
1. The cordyceps sinensis edible noodles with the effect of reducing high blood pressure, high blood lipid and high blood sugar are characterized by comprising the following raw materials in parts by weight: 100 parts of buckwheat flour, 80 parts of high gluten flour, 20 parts of cordyceps sinensis, 10 parts of linseed, 10 parts of oat, 5 parts of hawthorn, 5 parts of black fungus, 2 parts of corn, 2 parts of Chinese yam, 2 parts of tremella, 2 parts of black sesame, 2 parts of purple sweet potato, 2 parts of sunflower seed, 1 part of coix seed, 1 part of bitter gourd, 1 part of sodium carbonate, 1 part of kudzu root, 0.5 part of astragalus membranaceus, 0.5 part of cassia seed, 0.1 part of selfheal, 0.1 part of rehmannia and 0.2 part of edible salt.
2. The preparation method of the cordyceps sinensis edible noodles with the efficacy of reducing high blood pressure, high blood lipid and high blood sugar according to claim 1 is characterized by comprising the following steps:
s1, cleaning raw materials: respectively putting Cordyceps, fructus crataegi, herba Avenae Fatuae, Auricularia, semen Maydis, semen Lini, rhizoma Dioscoreae, Tremella, semen Sesami Niger, purple sweet potato, semen Helianthi, Coicis semen, fructus Momordicae Charantiae, radix Puerariae, semen Cassiae, radix astragali, Prunellae Spica, and rehmanniae radix into different containers, cleaning in cold water, taking out, draining water, pulverizing, and processing;
s2, crushing the raw materials: respectively crushing cleaned cordyceps sinensis, hawthorn, oat, black fungus, corn, flaxseed, Chinese yam, tremella, black sesame, purple sweet potato, sunflower seed, coix seed, bitter gourd, radix puerariae, cassia seed, astragalus mongholicus, selfheal and rehmannia root to ensure that the fineness of the raw materials meets the requirement of noodle making;
s3 mixing and stirring: pouring the crushed raw materials, buckwheat flour, high-gluten flour, edible salt, sodium carbonate and water into a stainless steel container, and fully stirring to form a smooth dough; the mass ratio of the added amount of the water to the buckwheat flour is 5: 4;
s4, making dough cover and noodles: putting the agglomerated mixed materials on a chopping board, and pressing the agglomerated mixed materials into dough sheets with uniform thickness by using a rolling pin; putting the pressed dough cover on a noodle machine, and pressing to form noodles with uniform length;
s5, drying, disinfecting and packaging: and (3) placing the prepared noodles in a sterile fume hood for dehydration and drying, then placing the noodles in an oven for heating and hot air drying, finally placing the noodles in a sterile room for natural cooling, and packaging and warehousing after passing inspection.
3. The preparation method of cordyceps sinensis edible noodles with efficacy of reducing high blood pressure, high blood lipid and high blood sugar according to claim 3, wherein the cleaning time in the step S1 is 3-5 min.
4. The preparation method of cordyceps sinensis edible noodles with efficacy of reducing high blood pressure, high blood lipid and high blood sugar according to claim 3, wherein in the step S2, the cordyceps sinensis edible noodles are sieved by a 100-mesh sieve plate during crushing.
5. The preparation method of cordyceps sinensis edible noodles with efficacy of reducing high blood pressure, high blood lipid and high blood sugar as claimed in claim 3, wherein in the step S3, the raw materials are fully stirred into a smooth dough and then are stopped for 18-22 min to wait for processing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010336896.6A CN111543587A (en) | 2020-04-26 | 2020-04-26 | Cordyceps sinensis edible noodles with effect of reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010336896.6A CN111543587A (en) | 2020-04-26 | 2020-04-26 | Cordyceps sinensis edible noodles with effect of reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111543587A true CN111543587A (en) | 2020-08-18 |
Family
ID=71996381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010336896.6A Pending CN111543587A (en) | 2020-04-26 | 2020-04-26 | Cordyceps sinensis edible noodles with effect of reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111543587A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114271435A (en) * | 2021-12-24 | 2022-04-05 | 张越今 | EGCG pure natural nutritional noodles with effect of reducing high blood pressure, high blood lipid and high blood sugar and production process thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106261613A (en) * | 2016-08-08 | 2017-01-04 | 陕西鑫易源农业科技开发有限公司 | A kind of Cordyceps flour noodle and preparation method thereof |
| CN106418178A (en) * | 2016-12-20 | 2017-02-22 | 绩溪袁稻农业产业科技有限公司 | Nutritional buckwheat noodles |
-
2020
- 2020-04-26 CN CN202010336896.6A patent/CN111543587A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106261613A (en) * | 2016-08-08 | 2017-01-04 | 陕西鑫易源农业科技开发有限公司 | A kind of Cordyceps flour noodle and preparation method thereof |
| CN106418178A (en) * | 2016-12-20 | 2017-02-22 | 绩溪袁稻农业产业科技有限公司 | Nutritional buckwheat noodles |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114271435A (en) * | 2021-12-24 | 2022-04-05 | 张越今 | EGCG pure natural nutritional noodles with effect of reducing high blood pressure, high blood lipid and high blood sugar and production process thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102919836B (en) | Health-care product capable of reducing blood glucose, releasing pressure, reducing lipid, relaxing bowel, beautifying, losing weight and resisting fatigue and production process thereof | |
| CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| CN102907604B (en) | Health-care product having effects of reducing blood sugar and pressure, losing weight, relaxing bowels, maintaining beauty and resisting fatigue and production process thereof | |
| CN101695376A (en) | Health-care food for preventing diabetes | |
| CN105995993A (en) | Food composition applicable to diabetic and preparation method thereof | |
| CN109315574A (en) | A kind of mulberry leaf balsam pear pressed candy | |
| WO2022068391A1 (en) | Composition capable of dispelling dampness and reducing fat, preparation method therefor and use thereof | |
| CN110585371A (en) | Spleen-tonifying qi-tonifying mind-tranquilizing medicine-food homologous traditional Chinese medicine composition and preparation method of spleen-tonifying qi-tonifying mind-tranquilizing paste | |
| CN100444746C (en) | A refined health food of high and cold mountain area crop and processing technology thereof | |
| CN106177183A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, green tea and Folium Mori | |
| CN106176953A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, Fructus Momordicae and Folium Mori | |
| CN104543767A (en) | Blood glucose-reduction dieto-therapeutic noodle and preparation method thereof | |
| CN105920439A (en) | Effective part composition containing corn stigma extract and preparation method and application of effective part composition | |
| CN111543587A (en) | Cordyceps sinensis edible noodles with effect of reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof | |
| CN106176952A (en) | A kind of health composition comprising leaf of Cyclocarya paliurus Iljinskaja and Folium Ilicis | |
| CN1957972B (en) | Composition in use for invigorating primordial energy, benefiting pubic region, preparation method and usage | |
| CN105876439A (en) | Immunity-enhancing and fatigue-resisting traditional Chinese medicine health-care product and preparation method thereof | |
| CN101116686A (en) | Medicine for treating fatness and its complication | |
| CN106692760A (en) | Golden flower wine formula for preventing diabetes and preparation method thereof | |
| CN106177476A (en) | A kind of Hyperglycemic health care compositions comprising Herba Dendrobii and Pericarpium Citri Reticulatae | |
| CN108785589A (en) | Application of the intelligence development invigorating spleen prescription composition in preparing food | |
| CN110122750A (en) | A kind of health-nutrition mixed congee | |
| CN110226616A (en) | A kind of health care flower cake | |
| CN105920271A (en) | Hypolipidemic composition and preparation method thereof | |
| CN114767794B (en) | Traditional Chinese medicine for treating arterial plaque |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200818 |